MedTrace Logo

Understanding CARdiac Events in Breast Cancer

NCT05921279 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-07-25

No results posted yet for this study

Summary

In Ireland, over 3,000 patients are diagnosed with breast cancer annually, and 1 in 9 Irish women will be diagnosed with breast cancer in their lifetime. There is evidence that female breast cancer survivors are more likely to die of cardiovascular disease than their age-matched counterparts.

This research is focused on evaluating pathways for identifying, managing, and overcoming side effects of cancer therapies that can negatively impact quality-of-life and overall outcomes for women during and after cancer treatment. The Cardio-oncology research team at GUH plan to capitalize on their expertise in both cancer care and cardiology to develop a care pathway for cancer patients who are at increased risk of developing heart disease.

Conditions

Sponsors & Collaborators

  • HRB Clinical Research Facility Galway

    collaborator OTHER

  • CORRIB Research Centre for Advanced Imaging and Core Lab, Galway, Ireland

    collaborator UNKNOWN

  • National University of Ireland, Galway, Ireland

    lead OTHER

Principal Investigators

  • Osama Soliman, MBBCh, PhD · NUIG

  • Aoife Lowery, MBBCh, PhD · NUIG

  • Michael Kerin, MD, PhD · NUIG

  • William Wijns, MD, PhD · NUIG

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-14
Primary Completion
2026-01-31
Completion
2026-07-31

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05921279 on ClinicalTrials.gov